Table of Contents
Overview of Adaptive Immunity 🧬
Adaptive immunity is the part of the immune system that learns from experience. It responds specifically to particular microbes or foreign substances and improves its response on repeated exposure. It is slower to start than innate immunity, but it is more precise and has memory. Adaptive immunity is mediated mainly by lymphocytes, especially B cells and T cells, and by the antibodies and cytokines they produce.
Adaptive immunity can be divided into humoral immunity, which is antibody mediated and mainly involves B cells, and cell mediated immunity, which mainly involves T cells. Both arms work together and communicate constantly through antigen presenting cells and cytokines.
Key Features of Adaptive Immunity 🎯
Adaptive immunity has several defining properties that distinguish it from innate immunity. These properties are crucial for understanding how vaccines work and how the body deals with repeat infections.
The first is specificity. Cells of the adaptive immune system recognize particular molecular structures called antigens. Each B cell receptor or T cell receptor is specific for one antigenic determinant, also called an epitope. This specificity allows targeted responses to different pathogens.
The second is diversity. The immune system can recognize an enormous variety of antigens. This diversity arises from genetic rearrangements of receptor genes in developing lymphocytes. As a result, the body can theoretically recognize millions of distinct antigens.
The third is memory. After the first exposure to an antigen, some activated lymphocytes become long lived memory cells. On re exposure, these memory cells respond faster and more strongly than naive cells. This is why second infections are often milder and why vaccines provide protection.
The fourth is self versus non self discrimination. Adaptive immunity usually ignores normal host tissues and responds to foreign antigens. This tolerance to self depends on deletion or inactivation of self reactive lymphocytes during development and on regulatory mechanisms in the periphery. Failure of tolerance contributes to autoimmune diseases, which are covered in another chapter.
Finally, adaptive responses are clonal and regulated. Each lymphocyte clone with a particular receptor either expands or remains silent depending on the presence of antigen and co stimulatory signals. Once the antigen is cleared, most effector cells die off and the response contracts.
Key properties of adaptive immunity: specificity, diversity, memory, self versus non self discrimination, and clonal expansion with regulation.
Antigens and Epitopes 🔬
An antigen is any substance that can be recognized by the adaptive immune system and can bind to a B cell receptor, a T cell receptor, or an antibody. Antigens are often proteins, but they can also be polysaccharides and, less commonly, lipids or nucleic acids when presented in certain forms.
Within an antigen, the specific part recognized by a receptor or antibody is called an epitope or antigenic determinant. A single protein antigen usually contains many different epitopes. Different B cells and T cells may recognize different epitopes on the same antigen.
B cell receptors and antibodies recognize epitopes that are accessible on the surface of intact antigens. These epitopes can be linear, based on a short sequence of amino acids, or conformational, based on the three dimensional folding of the protein. T cell receptors recognize only peptide epitopes that have been processed and presented on major histocompatibility complex molecules, which is discussed more formally in other immunology chapters.
An antigen that can stimulate an immune response by itself is called an immunogen. Some small molecules, called haptens, are not immunogenic alone but can become immunogenic when attached to a larger carrier protein. This principle is often used in experimental immunology and helps explain some drug allergies.
An epitope is the specific site on an antigen that is recognized by a B cell receptor, antibody, or T cell receptor. A single antigen usually contains multiple distinct epitopes.
Humoral Immunity and B Cells 🧪
Humoral immunity is mediated by B lymphocytes and the antibodies that they produce. It is particularly effective against extracellular microbes and the toxins they produce. B cells originate and mature in the bone marrow. During development, each B cell rearranges immunoglobulin genes to create a unique B cell receptor. This process generates the vast diversity of antibody specificity.
When a naive B cell first encounters its specific antigen, it binds the antigen through the B cell receptor. In many cases, especially for protein antigens, full activation of B cells also requires help from helper T cells, which recognize peptides from the same antigen presented on major histocompatibility complex class II molecules on the B cell surface. This interaction provides co stimulatory signals and cytokines that promote B cell proliferation and differentiation.
After activation, B cells undergo clonal expansion. Some activated B cells differentiate into plasma cells, which are specialized for high rate antibody secretion. Others become memory B cells that persist long term and respond rapidly on re exposure to the same antigen.
Antibodies, also called immunoglobulins, are the soluble form of the B cell receptor. They circulate in blood and tissue fluids and can also be present at mucosal surfaces. Antibodies have two main functional regions. The variable region binds antigen. The constant region determines the class or isotype such as IgM, IgG, IgA, IgE, or IgD and interacts with other components of the immune system, such as complement or Fc receptors on phagocytes.
Different antibody isotypes have different main locations and functions. For example IgM is the first isotype produced in a primary response and is effective at complement activation. IgG is the main antibody in blood and tissues and crosses the placenta. IgA is important in mucosal secretions. IgE participates in defense against parasites and in immediate hypersensitivity. Details of isotypes and effector mechanisms are discussed more deeply in other chapters.
Activated B cells differentiate into plasma cells that secrete antibodies and memory B cells that provide a faster and stronger response upon re exposure to the same antigen.
Cell Mediated Immunity and T Cells 🧫
Cell mediated immunity is primarily carried out by T lymphocytes. It is especially important for defense against intracellular pathogens such as viruses and some bacteria and against tumor cells. It also plays a role in rejection of transplanted tissues and in some autoimmune conditions.
T cells develop from precursors in the bone marrow and complete their maturation in the thymus. During development, T cells rearrange genes that encode the T cell receptor. Each mature T cell expresses a unique T cell receptor with a specific antigen binding site. Unlike B cells, T cells recognize antigen only in the form of peptide fragments displayed on major histocompatibility complex molecules on the surface of antigen presenting cells or target cells.
There are several main functional subsets of T cells. Cytotoxic T cells usually express CD8 and recognize peptides presented by major histocompatibility complex class I on infected or abnormal cells. When activated, they can directly kill these target cells using perforin and granzymes or through other mechanisms. Helper T cells usually express CD4 and recognize peptides presented by major histocompatibility complex class II on professional antigen presenting cells such as dendritic cells, macrophages, and B cells.
Helper T cells do not kill target cells directly. Instead they secrete cytokines that coordinate and regulate other immune cells. Different subsets of helper T cells such as Th1, Th2, Th17, and T follicular helper cells promote different types of immune responses, for example activation of macrophages, stimulation of B cell antibody production, or recruitment of neutrophils. The details of these subsets belong to other chapters on immunology.
T cells also include regulatory T cells that help maintain tolerance and prevent excessive immune responses. Regulatory T cells can suppress activation and proliferation of other lymphocytes. They are important in preventing autoimmunity and limiting tissue damage during immune responses.
T cells recognize peptide antigens only when presented on major histocompatibility complex molecules. CD8 T cells interact with class I, and CD4 T cells interact with class II.
Primary and Secondary Immune Responses ⏱️
The first time an individual encounters a particular antigen, the adaptive immune system mounts a primary response. During this response, there is a lag phase while antigen is processed, appropriate B and T cells are activated, and clonal expansion occurs. For antibodies, the primary response is characterized by a slower rise in antibody levels and by early predominance of IgM isotype, followed later by class switching to other isotypes.
Once the antigen is cleared, most effector cells die through apoptosis, and antibody levels decline. However, a subset of B and T cells persists as memory cells. These memory cells are more easily activated and more numerous than naive cells with the same specificity.
On subsequent exposure to the same antigen, the adaptive immune system generates a secondary or anamnestic response. This response is faster, larger, and more effective than the primary response. Antibody levels rise more quickly and reach higher peaks. The response is dominated by IgG or other switched isotypes rather than IgM. T cell responses are also more rapid and efficient. This enhanced secondary response is the basis for long lasting protection provided by vaccines.
A simplified comparison appears in the following table.
| Feature | Primary response | Secondary response |
|---|---|---|
| Lag time | Longer | Shorter |
| Peak antibody level | Lower | Higher |
| Main early isotype | IgM | IgG or other switched isotypes |
| Memory cell involvement | Memory cells generated | Memory cells reactivated |
| Clinical significance | Often symptomatic infection | Often milder or asymptomatic reinfection |
Secondary immune responses are faster, stronger, and more specific, and are dominated by memory cells and class switched antibodies, especially IgG.
Clonal Selection and Clonal Expansion 🌱
Clonal selection is a central concept in adaptive immunity. Before antigen exposure, the body contains many different lymphocyte clones. Each clone has unique receptors and is specific for a particular antigen epitope. These clones exist in small numbers while naive.
When an antigen enters the body, it selects the specific clones whose receptors can bind that antigen. Only those lymphocytes that recognize the antigen receive signals to become activated. After activation, these specific lymphocytes undergo clonal expansion. They proliferate and generate large numbers of effector cells that carry out the immune response against the antigen, as well as memory cells that persist long term.
The key idea is that antigen does not instruct the immune system how to recognize it. Instead, antigen selects from pre existing diverse clones. The variety of receptors arises randomly during lymphocyte development through gene rearrangement, which is covered elsewhere.
This clonal model explains both specificity and memory. Specificity comes from the unique receptors on each clone. Memory comes from the persistence of selected clones after the infection has resolved. It also explains tolerance. Self reactive clones are usually deleted or inactivated early in development so they are not available for selection by self antigens.
In clonal selection, antigen selects pre existing lymphocyte clones with specific receptors. These clones then undergo clonal expansion to produce many effector and memory cells.
Collaboration of B Cells, T Cells, and Antigen Presenting Cells 🤝
Adaptive immunity relies on cooperation between different cell types. Antigen presenting cells such as dendritic cells, macrophages, and B cells take up antigens, process them, and display peptides on major histocompatibility complex molecules. This presentation is essential for T cell activation.
Naive T cells encounter antigen presenting cells mainly in lymphoid organs such as lymph nodes and the spleen. If a T cell receptor recognizes a presented peptide and receives appropriate co stimulatory signals, the T cell becomes activated and differentiates into an effector or memory cell. Helper T cells then assist B cells and other immune cells through direct contact and cytokines.
B cells can act both as responders and as antigen presenting cells. They can bind antigen through their B cell receptor, internalize it, and present the processed peptides on major histocompatibility complex class II molecules to helper T cells. In return, helper T cells provide signals that allow B cells to class switch, increase antibody affinity, and differentiate into plasma cells and memory cells.
This triangular relationship between antigen presenting cells, T cells, and B cells ensures that strong adaptive responses require coordinated recognition of the same antigen. It reduces the chance of inappropriate activation and contributes to the specificity and regulation of the system.
Effective adaptive immunity typically requires antigen presentation to T cells, T cell help, and B cell activation, all focused on the same antigen to ensure specificity and regulation.
Active and Passive Adaptive Immunity 💉
Adaptive immunity can be acquired either actively or passively. In active immunity, the person’s own immune system is stimulated to produce an adaptive response and to form memory cells. This occurs after natural infection or after vaccination. Because memory cells are produced, active immunity is usually long lasting, sometimes lifelong.
In passive immunity, antibodies or immune cells are transferred from one individual to another. The recipient obtains immediate protection, but because the recipient’s own immune system has not been activated to produce memory cells, the protection is temporary. Examples include maternal IgG crossing the placenta, IgA in breast milk, and therapeutic administration of immune globulin preparations for certain infections or toxins.
The following table summarizes the main differences.
| Feature | Active immunity | Passive immunity |
|---|---|---|
| Source of antibodies | Produced by the person’s own immune system | Transferred from another person or animal |
| Onset of protection | Delayed, after response develops | Immediate |
| Duration | Long lasting, often years | Short term, weeks to months |
| Memory cell formation | Yes | No |
| Example | Infection, vaccination | Maternal antibodies, immune globulin therapy |
Active immunity involves the host producing its own response and memory and is long lasting. Passive immunity involves transfer of antibodies and is rapid but temporary, without memory.
Clinical Relevance of Adaptive Immunity 🩺
Understanding adaptive immunity is essential for many clinical topics that appear in licensing exams. Vaccinology relies on induction of active adaptive immunity and formation of memory cells. Immunodeficiency disorders often involve defects in B cells, T cells, or both, leading to increased susceptibility to infections. Hypersensitivity reactions, autoimmune diseases, and transplant rejection all involve inappropriate or misdirected adaptive immune responses.
Knowledge of primary and secondary responses helps interpret vaccine schedules, booster doses, and serologic tests. For example, detection of specific IgM often suggests a recent primary infection, while IgG may indicate past exposure, immunity, or a secondary response. Many targeted therapies in oncology and rheumatology, such as monoclonal antibodies and immune checkpoint inhibitors, act on components of adaptive immunity.
These clinical topics are covered in more detail in other chapters. At this stage, it is important to have a clear conceptual understanding of how adaptive immunity works at a basic level, how it differs from innate immunity, and why its properties of specificity, memory, and regulation are central to human health and disease.